Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.

Harris A, Selling D, Luther C, Hershberger J, Brittain J, Dickman S, Glick A, Lee JD.

Subst Abus. 2012;33(1):70-5. doi: 10.1080/08897077.2011.620479.

PMID:
22263715
2.

Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.

Awgu E, Magura S, Rosenblum A.

J Psychoactive Drugs. 2010 Sep;42(3):339-46.

3.

Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.

Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, Rosenblum A.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30. doi: 10.1016/j.drugalcdep.2008.08.006. Epub 2008 Oct 18.

4.

A randomized trial of methadone initiation prior to release from incarceration.

McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD.

Subst Abus. 2012;33(1):19-29. doi: 10.1080/08897077.2011.609446.

5.

Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N.

Lancet. 2015 Jul 25;386(9991):350-9. doi: 10.1016/S0140-6736(14)62338-2. Epub 2015 May 28.

6.

Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.

Lacroix I, Berrebi A, Garipuy D, Schmitt L, Hammou Y, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C.

Eur J Clin Pharmacol. 2011 Oct;67(10):1053-9. doi: 10.1007/s00228-011-1049-9. Epub 2011 May 3.

PMID:
21538146
7.

Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.

Trigg BG, Dickman SL.

Subst Abus. 2012;33(1):76-84. doi: 10.1080/08897077.2011.611455.

PMID:
22263716
8.

Assessing need for medication-assisted treatment for opiate-dependent prison inmates.

Albizu-García CE, Caraballo JN, Caraballo-Correa G, Hernández-Viver A, Román-Badenas L.

Subst Abus. 2012;33(1):60-9. doi: 10.1080/08897077.2011.620462.

9.

The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates.

Tomasino V, Swanson AJ, Nolan J, Shuman HI.

Mt Sinai J Med. 2001 Jan;68(1):14-20.

PMID:
11135501
10.

Consumer attitudes about opioid addiction treatment: a focus group study in New York City.

Sohler NL, Weiss L, Egan JE, López CM, Favaro J, Cordero R, Cunningham CO.

J Opioid Manag. 2013 Mar-Apr;9(2):111-9. doi: 10.5055/jom.2013.0152.

11.

Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.

Curcio F, Franco T, Topa M, Baldassarre C; Gruppo Responsabili UO Sert T.

Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):871-4.

PMID:
21845796
12.

Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.

Fox AD, Maradiaga J, Weiss L, Sanchez J, Starrels JL, Cunningham CO.

Addict Sci Clin Pract. 2015 Jan 16;10:2. doi: 10.1186/s13722-014-0023-0.

13.

Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.

Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, Somaini L.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):483-9. doi: 10.1016/j.pnpbp.2010.12.002. Epub 2010 Dec 10.

PMID:
21147192
14.

Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.

Farnia M, Ebrahimi B, Shams A, Zamani S.

Int J Drug Policy. 2010 Sep;21(5):422-4. doi: 10.1016/j.drugpo.2010.03.008. Epub 2010 Apr 21. Review.

PMID:
20413287
15.

Buprenorphine versus methadone maintenance for opioid dependence.

Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J.

J Nerv Ment Dis. 1993 Jun;181(6):358-64.

PMID:
8501457
16.

The effectiveness of opioid maintenance treatment in prison settings: a systematic review.

Hedrich D, Alves P, Farrell M, Stöver H, Møller L, Mayet S.

Addiction. 2012 Mar;107(3):501-17. doi: 10.1111/j.1360-0443.2011.03676.x. Review.

PMID:
21955033
17.
18.

Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.

McKeganey N, Russell C, Cockayne L.

J Subst Abuse Treat. 2013 Jan;44(1):97-102. doi: 10.1016/j.jsat.2012.04.003. Epub 2012 Jun 15.

PMID:
22703715
19.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
20.

Outcome evaluation of the opioid agonist maintenance treatment in Iran.

Esmaeili HR, Ziaddinni H, Nikravesh MR, Baneshi MR, Nakhaee N.

Drug Alcohol Rev. 2014 Mar;33(2):186-93. doi: 10.1111/dar.12112. Epub 2014 Jan 16.

PMID:
24428135
Items per page

Supplemental Content

Write to the Help Desk